Stockreport

Alzheimer’s Drug Could Mean $2 Billion Opportunity for Axovant [Bloomberg Business News]

Axon Enterprise, Inc.  (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.axovant.com/investors/sec-filings
PDF For a disease without a cure, and a field of drug development prone to disappointments , Axovant Sciences may be the next great hope. By month’s end, pivotal [Read more]